COVID-19 Antivirals Utilization Geographic and Demographic Patterns of Treatment in 2022
Murphy, S., Samson, L., and Sommers, B. (2022). COVID-19 Antivirals Utilization: Geographic and Demographic Patterns of Treatment in 2022. Office of the Assistant Secretary for Planning and Evaluation.
This report examines the utilization of oral antiviral medications, Paxlovid and Lagevrio, for the treatment of COVID-19. The analyses include an examination of time trends of COVID-19 antiviral use as well as breakdowns by age cohorts and gender, and find wide variation in COVID-19 antiviral medication use by state. Analysis on antiviral utilization can inform which populations may be most impacted by the shift of COVID-19 antiviral medications to the commercial market.
Login to rate, favorite, and comments on the article
You must Login to add a comment
- This item doesn't have any comments